Preliminary screening of the potential active ingredients in traditional Chinese medicines using the Ussing chamber model combined with HPLC-PDA-MS

被引:6
作者
Wang, Dandan [1 ,2 ]
Liu, Rui [3 ]
Zeng, Jinxiang [4 ]
Li, Chunhu [2 ]
Xiang, Wei [2 ]
Zhong, Guoyue [4 ]
Xia, Zhining [1 ,2 ,3 ]
机构
[1] Southwest Med Univ, Sch Pharm, Luzhou 646000, Sichuan, Peoples R China
[2] Chongqing Univ, Sch Pharmaceut Sci, Chongqing 401331, Peoples R China
[3] Chongqing Univ, Sch Chem & Chem Engn, Chongqing 401331, Peoples R China
[4] Jiangxi Univ Tradit Chinese Med, Res Ctr Nat Resources Chinese Med Mat & Ethn Med, Nanchang 330004, Jiangxi, Peoples R China
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2022年 / 1189卷
关键词
In vitro intestinal absorption; Ussing chamber model; Traditional Chinese medicines; Potential active ingredients; Multi-component system; HPLC-PDA-MS; ANTIOXIDANT ACTIVITY; MECHANISMS; EPIMEDIUM;
D O I
10.1016/j.jchromb.2021.123090
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
An in vitro intestinal absorption model combined with high-performance liquid chromatography-photo diode array-tandem mass spectrometry (HPLC-PDA-MS) was used for preliminary screening of potential active ingredients from complex multi-component traditional Chinese medicine (TCM) system. Oral administration is one of the main administration methods for TCMs. Only the ingredients that could be absorbed have the opportunity to play a role. Thus, these were defined as potential active ingredients. Studying of intestinal absorption can provide a theoretical basis for the mechanism of TCMs. The Caco-2 cell model, the everted rat gut sac model, and the Ussing chamber model were established for TCMs. The degree of anastomosis between the in vitro intestinal model and the actual intestinal absorption of TCMs were evaluated by the gavage method in rats. The Ussing chamber model was best fit for oral experiments in rats and was selected as the research means to preliminarily screen potential active ingredients from eight TCMs, including Salvia miltiorrhiza Bunge, Astragalus propinquus Schischkin, Plantago asiatica L, Fallopia multiflora (Thunb.) Harald, Epimedium brevicornu Maxim, Moutan Cortex, Citrus reticulata Blanco, and Panax notoginseng (Burkill) F. H. Chen ex C. H. Chow. A total of 44 components were absorbed and screened as the potential active ingredients from the 80 components identified in eight TCMs by HPLC-PDA-MS.
引用
收藏
页数:14
相关论文
共 38 条
  • [1] Identification of antioxidant constituents of the aerial part of Plantago asiatica using LC-MS/MS coupled DPPH assay
    Ahn, Jong Hoon
    Jo, Yang Hee
    Kim, Seon Beom
    Turk, Ayman
    Oh, Kyung-Eon
    Hwang, Bang Yeon
    Lee, Ki Yong
    Lee, Mi Kyeong
    [J]. PHYTOCHEMISTRY LETTERS, 2018, 26 : 20 - 24
  • [2] The direct evidence and mechanism of traditional Chinese medicine treatment of COVID-19
    An, Xuedong
    Zhang, YueHong
    Duan, Liyun
    Jin, De
    Zhao, Shenghui
    Zhou, RongRong
    Duan, Yingying
    Lian, Fengmei
    Tong, Xiaolin
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2021, 137
  • [3] A clinical care competency inventory for nurses in Traditional Chinese Medicine: Development and psychometric evaluation
    Chang, Miao-Ju
    Hsieh, Suh-Ing
    Huang, Tzu-Hsin
    Hsu, Li-Ling
    [J]. NURSE EDUCATION IN PRACTICE, 2020, 49
  • [4] Preparation, characterization and antioxidant activity of polysaccharide from Fallopia multiflora (Thunb.) Harald
    Chen, Li
    Zhang, Yipeng
    Jin, Lixin
    Gao, Renjiao
    Bao, Jiaqi
    Cui, Bowen
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2018, 108 : 259 - 262
  • [5] Differentiated Caco-2 cell models in food-intestine interaction study: Current applications and future trends
    Ding, Xiaomeng
    Hu, Xiaoyi
    Chen, Yi
    Xie, Jianhua
    Ying, Mengxi
    Wang, Yudan
    Yu, Qiang
    [J]. TRENDS IN FOOD SCIENCE & TECHNOLOGY, 2021, 107 : 455 - 465
  • [6] Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2
    Du, Ashuai
    Zheng, Rong
    Disoma, Cyrollah
    Li, Shiqin
    Chen, Zongpeng
    Li, Sijia
    Liu, Pinjia
    Zhou, Yuzheng
    Shen, Yilun
    Liu, Sixu
    Zhang, Yongxing
    Dong, Zijun
    Yang, Qinglong
    Alsaadawe, Moyed
    Razzaq, Aroona
    Peng, Yuyang
    Chen, Xuan
    Hu, Liqiang
    Peng, Jian
    Zhang, Qianjun
    Jiang, Taijiao
    Mo, Long
    Li, Shanni
    Xia, Zanxian
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 176 : 1 - 12
  • [7] Ginsenosides for the treatment of metabolic syndrome and cardiovascular diseases: Pharmacology and mechanisms
    Fan, Wenxiang
    Huang, Yongliang
    Zheng, Hui
    Li, Shuiqin
    Li, Zhuohong
    Yuan, Li
    Cheng, Xi
    He, Chengshi
    Sun, Jianfeng
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2020, 132
  • [8] Anti-inflammatory effect of rosmarinic acid isolated from Blechnum brasiliense in adult zebrafish brain
    Fasolo, Juliana M. M. A.
    Vizuete, Adriana Fernanda K.
    Rico, Eduardo P.
    Rambo, Renata B. S.
    Toson, Natally S. B.
    Santos, Emerson
    de Oliveira, Diogo L.
    Goncalves, Carlos A. S.
    Schapoval, Elfrides E. S.
    Heriques, Amelia T.
    [J]. COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY, 2021, 239
  • [9] Antioxidation, anti-inflammation and anti-apoptosis by paeonol in LPS/D-GalN-induced acute liver failure in mice
    Gong, Xiaobao
    Yang, You
    Huang, Ligua
    Zhang, Qingyan
    Wan, Rong-Zhen
    Zhang, Peng
    Zhang, Baoshun
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 46 : 124 - 132
  • [10] The interactions between gut microbiota and bioactive ingredients of traditional Chinese medicines: A review
    Gong, Xue
    Li, Xue
    Bo, Agula
    Shi, Ru-Yu
    Li, Qin-Yu
    Lei, Lu-Jing
    Zhang, Lei
    Li, Min-Hui
    [J]. PHARMACOLOGICAL RESEARCH, 2020, 157